Nanogen and Epoch Bioscience to merge
This article was originally published in Clinica
Executive Summary
In keeping with its long-term strategy to grow its business in both the genetic and proteomic testing markets, Nanogen has acquired Epoch Biosciences, a Bothell, Washington company specialising in genomic analysis. The all-stock transaction is to expected to close by the end of 2004.